ATE480239T1 - Angiogeneseinhibitoren - Google Patents

Angiogeneseinhibitoren

Info

Publication number: ATE480239T1
Authority: AT; Austria
Prior art keywords: sub; optionally substituted; alkyl; hydrogen; compounds
Prior art date: 2005-06-09

Application number

AT05812885T

Other languages

English (en)

Inventor

Catherine Berset

Stephan Audetat

Julia Tietz

Tea Gunde

Alcide Barberis

Andreas Schumacher

Peter Traxler

Original Assignee

Oncalis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-09

Filing date

2005-12-09

Publication date

2010-09-15

2005-06-09 Priority claimed from PCT/CH2005/000321 external-priority patent/WO2005120513A1/en

2005-12-09 Application filed by Oncalis Ag filed Critical Oncalis Ag

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE480239T1 publication Critical patent/ATE480239T1/de

Links

229940121369 angiogenesis inhibitor Drugs 0.000 title 1
239000004037 angiogenesis inhibitor Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
150000002431 hydrogen Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000003107 substituted aryl group Chemical group 0.000 abstract 2
101100516568 Caenorhabditis elegans nhr-7 gene Chemical group 0.000 abstract 1
102000001253 Protein Kinase Human genes 0.000 abstract 1
230000033115 angiogenesis Effects 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
108060006633 protein kinase Proteins 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT05812885T 2005-06-09 2005-12-09 Angiogeneseinhibitoren ATE480239T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/CH2005/000321 WO2005120513A1 (en)	2004-06-09	2005-06-09	Protein kinase inhibitors
PCT/CH2005/000736 WO2006131003A1 (en)	2005-06-09	2005-12-09	Angiogenesis inhibitors

Publications (1)

Publication Number	Publication Date
ATE480239T1 true ATE480239T1 (de)	2010-09-15

Family

ID=35636719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05812885T ATE480239T1 (de)	2005-06-09	2005-12-09	Angiogeneseinhibitoren

Country Status (6)

Country	Link
EP (1)	EP1901748B1 (de)
AT (1)	ATE480239T1 (de)
AU (1)	AU2005332594A1 (de)
CA (1)	CA2611391A1 (de)
DE (1)	DE602005023544D1 (de)
WO (1)	WO2006131003A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2008015747A (es)	2006-06-06	2008-12-19	Schering Corp	Imidazopirazinas como inhibidores de la proteina quinasa.
CN101855222A (zh) *	2007-05-10	2010-10-06	通用电气健康护理有限公司	对大麻素cb2受体具有活性的咪唑并(1,2-a)吡啶和相关化合物
WO2010083617A1 (en)	2009-01-21	2010-07-29	Oncalis Ag	Pyrazolopyrimidines as protein kinase inhibitors
WO2011009695A1 (en)	2009-07-21	2011-01-27	Universität Zürich	New anti-angiogenic compounds
US9493450B2 (en)	2014-02-13	2016-11-15	Incyte Corporation	Cyclopropylamines as LSD1 inhibitors
EP3392244A1 (de)	2014-02-13	2018-10-24	Incyte Corporation	Cyclopropylamine als lsd1-inhibitoren
WO2015123437A1 (en)	2014-02-13	2015-08-20	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
PE20161573A1 (es)	2014-02-13	2017-01-19	Incyte Corp	Ciclopropilamina como inhibidor de la lsd1
WO2016007722A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TWI687419B (zh)	2014-07-10	2020-03-11	美商英塞特公司	作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
US9695180B2 (en)	2014-07-10	2017-07-04	Incyte Corporation	Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
WO2016007727A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
PE20180455A1 (es)	2015-04-03	2018-03-05	Incyte Corp	Compuestos heterociclicos como inhibidores de lsd1
SG10202001219UA (en)	2015-08-12	2020-03-30	Incyte Corp	Salts of an lsd1 inhibitor
CN109414410B (zh)	2016-04-22	2022-08-12	因赛特公司	Lsd1抑制剂的制剂
AU2018346331B2 (en) *	2017-10-04	2023-08-24	Dana-Farber Cancer Institute, Inc.	Small molecule inhibition of transcription factor SALL4 and uses thereof
WO2020047198A1 (en)	2018-08-31	2020-03-05	Incyte Corporation	Salts of an lsd1 inhibitor and processes for preparing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU779197B2 (en) *	1999-10-08	2005-01-13	Grunenthal Gmbh	Bicyclic imidazo-3-yl-amine derivatives

2005
- 2005-12-09 EP EP05812885A patent/EP1901748B1/de not_active Expired - Lifetime
- 2005-12-09 AT AT05812885T patent/ATE480239T1/de not_active IP Right Cessation
- 2005-12-09 AU AU2005332594A patent/AU2005332594A1/en not_active Abandoned
- 2005-12-09 CA CA002611391A patent/CA2611391A1/en not_active Abandoned
- 2005-12-09 DE DE602005023544T patent/DE602005023544D1/de not_active Expired - Lifetime
- 2005-12-09 WO PCT/CH2005/000736 patent/WO2006131003A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP1901748A1 (de)	2008-03-26
WO2006131003A1 (en)	2006-12-14
EP1901748B1 (de)	2010-09-08
DE602005023544D1 (de)	2010-10-21
CA2611391A1 (en)	2006-12-14
AU2005332594A1 (en)	2006-12-14

Similar Documents

Publication	Publication Date	Title
ATE480239T1 (de)	2010-09-15	Angiogeneseinhibitoren
EA201290260A1 (ru)	2013-12-30	Бензимидазол-имидазольные производные
EA201101566A1 (ru)	2012-05-30	Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ
NO20082934L (no)	2008-09-02	Antivirale nukleotider
CY1108792T1 (el)	2014-04-09	Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
EA201000947A1 (ru)	2011-02-28	Производные тиазола, применимые в качестве ингибиторов киназы pi3
EA201000113A1 (ru)	2010-08-30	Пиразольные соединения
AR054799A1 (es)	2007-07-18	Derivados de oxindol
NO20074641L (no)	2007-11-01	1-Acetic Acid-Indole Derivatives with PGD2 Antagonist Activity
HRP20050533A2 (en)	2006-11-30	Aminoindazole derivatives and use thereof as kinase inhibitors
DE602006007012D1 (de)	2009-07-09	Pyridinderivate als dipeptedyl-peptidase-hemmer
CY1115536T1 (el)	2017-01-04	Νεες υδροξυ-6-ετεροαρυλφαινανθριδινες και χρηση αυτων ως αναστολεις pde4
AR052866A1 (es)	2007-04-11	Fenil-metanonas monociclicas sustituidas
MX2010000658A (es)	2010-03-26	Derivados de pirimidina 934.
CY1112679T1 (el)	2016-02-10	Κινολινες και θεραπευτικη χρηση αυτων
MX2010002938A (es)	2010-04-01	Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
EA201071012A1 (ru)	2011-04-29	Производные азетидинов, способ их получения и применение их в терапии
DE602007001463D1 (de)	2009-08-13	Pyrimidin-, chinazolin-, pteridin- und triazinderivate
DE602005014804D1 (de)	2009-07-16	Substituierte 5-carboxyamidpyrazoles und ä1,2,4ütriazole als viruzide
EA200701779A1 (ru)	2008-02-28	Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
EA200702058A1 (ru)	2008-02-28	Новые фармацевтические соединения
EA201070010A1 (ru)	2010-06-30	Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
ATE492534T1 (de)	2011-01-15	1h-indol-5-ylpiperazin-1-ylmethanonderivate
EA200700758A1 (ru)	2007-10-26	Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ
NO20082226L (no)	2008-07-01	6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties